|
|
|
Insider
Information: |
Tooman Craig A |
Relationship: |
President and CEO, Dir... |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
160,480 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,862 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
160,480 |
|
|
Total
Value |
$20,862 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Enzon Pharmaceuticals Inc |
ENZN |
Exec VP Finance, CFO |
2010-06-18 |
160,480 |
2005-01-05 |
0 |
Premium* |
|
Aratana Therapeutics, Inc. |
PETX |
President and CEO, Dir... |
2019-07-18 |
0 |
2013-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PETX |
Aratana Therapeutics, Inc... |
President and CEO |
|
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(307,501) |
0 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Executive Vice President |
|
2005-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2006-03-07 |
4 |
B |
$6.87 |
$6,868 |
D/D |
1,000 |
26,000 |
2.74 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2013-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
44,550 |
44,550 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
EVP, Finance & CFO |
|
2007-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
51,000 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2007-05-11 |
4 |
B |
$8.19 |
$8,190 |
D/D |
1,000 |
52,000 |
2.74 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2014-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
54,550 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2015-11-09 |
4 |
AS |
$7.52 |
$27,238 |
D/D |
(3,620) |
69,980 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2016-09-09 |
4 |
AS |
$9.25 |
$277,599 |
D/D |
(30,000) |
72,424 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2015-10-02 |
4 |
AS |
$8.06 |
$26,189 |
D/D |
(3,250) |
73,600 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2018-01-11 |
4 |
AS |
$5.27 |
$158,040 |
D/D |
(30,000) |
75,024 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2015-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,300 |
76,850 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2016-02-01 |
4 |
AS |
$3.36 |
$9,436 |
D/D |
(2,806) |
102,424 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2017-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,600 |
103,024 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2017-12-21 |
4 |
OE |
$3.14 |
$6,280 |
D/D |
2,000 |
105,024 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2016-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
35,250 |
105,230 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2009-01-17 |
4 |
S |
$6.33 |
$65,237 |
D/D |
(10,306) |
108,806 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
EVP, FINANCE, CFO |
|
2008-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
109,500 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-17 |
4 |
D |
$10.91 |
$103,056 |
D/D |
(9,446) |
114,164 |
0 |
- |
|
PETX |
Aratana Therapeutics, Inc... |
CHIEF FINANCIAL OFFICER |
|
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
39,700 |
114,724 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2008-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
116,122 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2009-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
26,667 |
119,112 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2008-11-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
119,122 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2009-04-03 |
4 |
S |
$6.12 |
$36,292 |
D/D |
(5,930) |
122,924 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Exec VP Finance, CFO |
|
2010-01-05 |
4 |
D |
$10.77 |
$44,771 |
D/D |
(4,157) |
123,610 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|